Ovid Therapeutics (1OT.F) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.1
0
0.11

Details

Expected EPS
-0.12288931671
Actual EPS
-0.12510820000000003
Surprise EPS
-0
Surprise Percent
-1.81%

Description

⁨Ovid Therapeutics⁩ (⁦1OT.F⁩) has reported earnings of ⁦-0.12510820000000003⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts